STERIS (STE) to Release Quarterly Earnings on Wednesday

STERIS (NYSE:STE) is expected to be issuing its Q4 2025 quarterly earnings data after the market closes on Wednesday, May 14th. Analysts expect the company to announce earnings of $2.58 per share and revenue of $1.47 billion for the quarter.

STERIS Price Performance

STE stock opened at $226.54 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. The business has a 50 day simple moving average of $223.40 and a 200-day simple moving average of $218.80. The firm has a market capitalization of $22.26 billion, a PE ratio of 48.10 and a beta of 0.96. STERIS has a 1 year low of $200.98 and a 1 year high of $248.24.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be given a $0.57 dividend. The ex-dividend date is Tuesday, June 10th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.01%. STERIS’s dividend payout ratio (DPR) is presently 48.41%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on STE shares. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. Stephens upgraded STERIS to a “strong-buy” rating in a research report on Thursday, May 1st. Piper Sandler increased their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. One investment analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.